Connor, Clark & Lunn Investment Management Ltd.

Position in PMVP — PMV Pharmaceuticals, Inc.

CIK 1596800 VANCOUVER, A1

Position in PMVP

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$43,496

+$3,246 QoQ

Shares Held

32,460

0.0% QoQ

Ownership

0.061%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#43

of 64 holders

Holding Since

Dec 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $648,992,404 across 104 Biotechnology names. PMVP ranks #102 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	135,236	$67,175,777
2	IONS	Ionis Pharmaceuticals Inc	684,236	$54,253,072
3	ARWR	Arrowhead Pharmaceuticals, Inc.	625,569	$50,990,129
4	MIRM	Mirum Pharmaceuticals, Inc.	420,063	$49,176,775
5	REGN	Regeneron Pharmaceuticals, Inc.	42,465	$26,478,625
6	AXSM	Axsome Therapeutics, Inc.	97,698	$23,913,539
7	INSM	INSMED Inc	212,676	$22,675,515
8	VKTX	Viking Therapeutics, Inc.	530,607	$20,698,979

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$43,496	32,460	0.0%	Shares	Sole	2026-08-13
2026-03-31	$40,250	32,460	-87.9%	Shares	Sole	2026-05-11
2025-03-31	$291,723	267,636	-27.8%	Shares	Sole	2025-05-12
2024-12-31	$560,089	370,920	-15.9%	Shares	Sole	2025-02-10
2024-09-30	$657,125	441,024	+0.4%	Shares	Sole	2024-11-08
2024-06-30	$711,405	439,139	+1.2%	Shares	Sole	2024-08-09
2024-03-31	$737,550	433,853	+134.4%	Shares	Sole	2024-05-09
2023-12-31	$573,881	185,123	+9.1%	Shares	Sole	2024-02-09
2023-09-30	$1,041,951	169,699	+3.5%	Shares	Sole	2023-11-13
2023-06-30	$1,026,402	163,962	+5.1%	Shares	Sole	2023-08-10
2023-03-31	$744,396	156,058	+34.9%	Shares	Sole	2023-05-10
2022-12-31	$1,006,494	115,689	—	Shares	Sole	2023-02-10
No filing history on record for this holder in this stock.